Dawei Wu

4.3k total citations
111 papers, 2.1k citations indexed

About

Dawei Wu is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Dawei Wu has authored 111 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 26 papers in Molecular Biology and 24 papers in Surgery. Recurrent topics in Dawei Wu's work include Cancer Immunotherapy and Biomarkers (12 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Cancer Genomics and Diagnostics (8 papers). Dawei Wu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Cancer Genomics and Diagnostics (8 papers). Dawei Wu collaborates with scholars based in China, United States and Australia. Dawei Wu's co-authors include Hao Wang, Jing Huang, Haipeng Guo, Hongnan Mo, Dong Qu, Bo Lan, Xuelian Chen, Binghe Xu, Weidong Qin and Chen Li and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Dawei Wu

104 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dawei Wu China	26	681	527	491	486	351	111	2.1k
Xue Wang China	26	634 0.9×	724 1.4×	399 0.8×	383 0.8×	218 0.6×	124	2.1k
Yan Shi China	30	947 1.4×	1.1k 2.0×	524 1.1×	548 1.1×	459 1.3×	191	3.4k
Haibo Qiu China	23	907 1.3×	532 1.0×	936 1.9×	540 1.1×	307 0.9×	141	2.6k
Limin Peng United States	34	692 1.0×	813 1.5×	613 1.2×	757 1.6×	347 1.0×	103	4.4k
Julius Špičák Czechia	21	733 1.1×	416 0.8×	440 0.9×	1.2k 2.6×	576 1.6×	130	2.8k
Ole Thorlacius‐Ussing Denmark	31	1.0k 1.5×	602 1.1×	390 0.8×	975 2.0×	322 0.9×	168	3.2k
Ronit Almog Israel	21	588 0.9×	339 0.6×	250 0.5×	524 1.1×	330 0.9×	68	2.2k
Gianluigi Zaza Italy	38	372 0.5×	1.3k 2.4×	474 1.0×	608 1.3×	583 1.7×	150	3.9k
Bo Jin China	26	427 0.6×	710 1.3×	208 0.4×	450 0.9×	262 0.7×	97	2.1k
María J. Gutiérrez United States	22	345 0.5×	560 1.1×	188 0.4×	893 1.8×	255 0.7×	88	2.4k

Countries citing papers authored by Dawei Wu

Since Specialization

Citations

This map shows the geographic impact of Dawei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Wu more than expected).

Fields of papers citing papers by Dawei Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Wu. The network helps show where Dawei Wu may publish in the future.

Co-authorship network of co-authors of Dawei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Dawei Wu. A scholar is included among the top collaborators of Dawei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawei Wu. Dawei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Li‐Ping, Fan Qiu, Dawei Wu, et al.. (2025). Crocetin, a versatile carotenoid: Novel insights into pharmacological effects, molecular mechanisms, and therapeutic potential. International Immunopharmacology. 162. 115125–115125.

Jiang, Yale, Ye Leng, Qing Wu, et al.. (2025). Understanding the gap between expectations and reality in decentralized clinical trials. npj Digital Medicine. 8(1). 408–408. 1 indexed citations

Wu, Dawei, Shujun Xing, Xin Wang, et al.. (2024). Personalized neoantigen cancer vaccines: current progression, challenges and a bright future. Clinical and Experimental Medicine. 24(1). 229–229. 17 indexed citations

Huang, Huiyao, Yu Tang, Dawei Wu, et al.. (2023). Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution. BMC Geriatrics. 23(1). 195–214. 4 indexed citations

Jiang, Ning, Yue Yu, Dawei Wu, et al.. (2023). HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events. Journal of Cancer Research and Clinical Oncology. 149(2). 737–747. 19 indexed citations

Wang, Bin, Dawei Wu, Kai Zhang, Huaqing Zhang, & Chao Zhang. (2023). Prediction Model of Fault Block Reservoir Measure Index Based on 1DCNN-LightGBM. Scientific Programming. 2023. 1–9. 1 indexed citations

Tang, Qiyu, Dawei Wu, Huiyao Huang, et al.. (2023). Adverse events of PD-(L)1 inhibitors plus anti-VEGF(R) agents compared with PD-(L)1 inhibitors alone for cancer patients: a systematic review and meta-analysis. Frontiers in Pharmacology. 14. 1093194–1093194. 3 indexed citations

Jia, Liqun, et al.. (2022). Nrf2 participates in the protective effect of exogenous mitochondria against mitochondrial dysfunction in myocardial ischaemic and hypoxic injury. Cellular Signalling. 92. 110266–110266. 9 indexed citations

Gan, Lin, Yan Chen, Peipei Hu, et al.. (2021). Willingness to Receive SARS-CoV-2 Vaccination and Associated Factors among Chinese Adults: A Cross Sectional Survey. International Journal of Environmental Research and Public Health. 18(4). 1993–1993. 54 indexed citations

10.

Lu, Guotao, Luyao Zhang, Lu Ke, et al.. (2021). Protectin D1 decreases pancreatitis severity in mice by inhibiting neutrophil extracellular trap formation. International Immunopharmacology. 94. 107486–107486. 15 indexed citations

11.

Huang, Huiyao, Huilei Miao, Jun Wang, et al.. (2021). Advances on anticancer new drugs in China and the USA in 2020: from ongoing trial to drug approval. SHILAP Revista de lepidopterología. 1(4). 147–152. 10 indexed citations

12.

Duan, Yanhua, Li Chen, Dawei Wu, et al.. (2020). Image quality and radiation dose of different scanning protocols in DSCT cardiothoracic angiography for children with tetralogy of fallot. International journal of cardiac imaging. 36(9). 1791–1799. 2 indexed citations

13.

Jiang, Shiyu, Sheng Yang, Jianliang Yang, et al.. (2019). Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China. BMJ Open. 9(5). e028589–e028589. 1 indexed citations

14.

Zhou, Min, Wei Li, Weidong Qin, et al.. (2019). Nasal pathogenic bacteria colonization and related risk factors among medical staff of intensive care unit. 5(1). 3–8. 1 indexed citations

15.

Chen, Xuelian, Hongnan Mo, Dawei Wu, et al.. (2019). Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210. Cancer Biology and Medicine. 16(1). 173–173. 46 indexed citations

16.

Huang, Jing, Binghe Xu, Hongnan Mo, et al.. (2018). Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma. Clinical Cancer Research. 24(6). 1296–1304. 149 indexed citations

17.

Wang, Wenna, Yunxia Tao, Xiao Lyu, et al.. (2016). Phase II and UGT1A1 Polymorphism Study of Two Different Irinotecan Dosages Combined with Cisplatin as First-Line Therapy for Advanced Gastric Cancer. Chemotherapy. 61(4). 197–203. 5 indexed citations

18.

Chen, Hairong, Yubo Liu, & Dawei Wu. (2015). Diffuse Calcification of the Urinary System and Miliary Tuberculosis Due To Delayed Diagnosis of Genitourinary Tuberculosis: A Case Report. SHILAP Revista de lepidopterología. 5 indexed citations

19.

Li, Chengjun, Jinbao Li, Dawei Wu, & Gang Han. (2015). The involvement of survivin in insulin-like growth factor 1-induced epithelial-mesenchymal transition in gastric cancer. Tumor Biology. 37(1). 1091–1096. 11 indexed citations

20.

Ou, Yang, Fangfang Guo, Qing Xie, et al.. (2014). Audits of the quality of perioperative antibiotic prophylaxis in Shandong Province, China, 2006 to 2011. American Journal of Infection Control. 42(5). 516–520. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact